Chelation of iron within the erythrocytic Plasmodium falciparum parasite by iron chelators

Molecular and Biochemical Parasitology

Volumn 101, Issue 1-2, 1999, Pages 43-59

  Loyevsky, Mark ^a   John, Christy ^b   Dickens, Benjamin ^b   Hu, Valerie ^b   Miller, J Houston ^c   Gordeuk, Victor R ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

Antimalarial iron chelators; Calcein; Plasmodia

Indexed keywords

AMINOPHENOL; AMINOPHENOL DERIVATIVE; ANTIMALARIAL AGENT; BIPYRIDINE; CALCEIN; CALCIUM; DEFEROXAMINE; HEMATIN; HEMOGLOBIN; IRON CHELATING AGENT;

ANTIMALARIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ERYTHROCYTE; FLUORESCENCE; HUMAN; HUMAN CELL; IRON CHELATION; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

2,2'-DIPYRIDYL; AMINOPHENOLS; ANIMALS; CALCIUM; CHELATING AGENTS; DEFEROXAMINE; ERYTHROCYTES; FLUORESCEINS; FLUORESCENT DYES; HUMANS; HYDROGEN-ION CONCENTRATION; IRON; IRON CHELATING AGENTS; MICROSCOPY, FLUORESCENCE; PLASMODIUM FALCIPARUM;

PLASMODIUM FALCIPARUM;

EID: 0032998958     PISSN: 01666851     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-6851(99)00053-5     Document Type: Article

References (52)

1. Raventos-Suarez C., Pollack S., Nagel R.L Plasmodium falciparum: inhibition in vitro growth by desferrioxamine. B. Am. J. Trop. Med. Hyg. 3:1982;919-922.
2. Whitehead S., Peto T.E.A. Stage-dependent effect of desferrioxamine on growth of Plasmodium falciparum in vitro. Blood. 76:1990;1250-1255.
3. Scheibel LW, Rodriguez S, Antimalarial activity of selected aromatic chelators V: localization of 59Fe in plasmodium falciparum in the presence of oxines. In: Eaton JW, Meshnik SR, Brewer GJ, editors. Malaria and the Red Cell 2. Proceedings of the Second Workshop on Malaria and the Red Cell, Ann Arbor, Michigan, October 24, 1988. New York: Alan R. Liss, 1989: 119-149.
4. Pollack S., Rosan D., Davidson D., Escajadillo A. Desferrioxamine suppresses P. falciparum in Aotus monkeys. Proc. Soc. Exp. Biol. Med. 184:1987;162-164.
5. Lytton S.L., Loyevsky M., Mester B., Libman J., Landau I., Shanzer A., Cabantchik Z.I. In vivo antimalarial action of a lipophilic Fe(III) chelator: suppression of Plasmodium vinckei infection by reversed siderophore. Am. J. Hematol. 43:1993;217-220.
6. Gordeuk V.R., Thuma P.E., Brittenham G.M., Zulu S., Simwanza G., Mhangu A., Flesch G., Parry D Fe chelation with desferrioxamine B in adults with asymptomatic Plasmodium falciparum parasitemia. Blood. 79:1992;308-312.
7. Bunnag D., Poltera A.A., Viravan C., Looareesuwan S., Harinasuta K.T., Schindlery C. Plasmodicidal effect of desferrioxamine B in human vivax and malaria from Thailand. Acta. Trop. 52:1992;59-67.
8. Rubin H., Salem J.S., Li L.S., Jang F.D., Mama S. et al. Cloning, sequence determination, and regulation of the ribonucleotide reductase subunits from Plasmodium falciparum. A target for antimalarial therapy. Proc. Natl. Acad. Sci. USA. 90:1993;9280-9284.
9. Surolia N., Padmanaban G. De novo biosynthesis of heme offers a new chemotherapeutic target in the human malarial parasite. Biochem. Biophys. Res. Commun. 187:1992;744-750.
10. Cabantchik Z.I., Glickstein H., Golenser J., Loyevsky M., Tsafack A. Fe chelators: mode of action as antimalarials. Acta Haematol. 95:1996;70-77.
11. Gamboa de Dominguez N., Rosenthal P.J. Cysteine proteinase inhibitors block early steps in hemoglobin degradation by cultured malaria parasites. Blood. 87:1996;4448-4454.
12. Sanchez-Lopez R., Haldar K. A transferrin-independent Fe uptake activity in Plasmodium falciparum-infected and uninfected erythrocytes. Mol. Biochem. Parasitol. 55:1992;9-20.
13. Rodriguez M.H., Jungery M. A protein on Plasmodium falciparum-infected erythrocytes functions as a transferrin receptor. Nature. 234:1986;388-391.
14. Haldar K., Henderson C.L., Cross G.A.M. Identification of the parasite transferrin receptor of Plasmodium falciparum-infected erythrocytes and its acylation via 1,2-diacyl-sn-glycerol. Proc. Natl. Acad. Sci. USA. 83:1986;8565-8569.
15. Pollack S., Fleming J. Plasmodium falciparum takes up Fe from transferrin. B. J. Haematol. 58:1984;289-293.
16. Gabay T., Ginsburg H. Hemoglobin denaturation and Fe release in acidified red blood cell lysate-a possible source of Fe for intraerythrocytic malaria parasites. Exp. Parasitol. 77:1993;261-272.
17. Hershko H., Peto T.E.A. Deferoxamine inhibition of malaria is independent of host Fe status. J. Exp. Med. 168:1988;375-387.
18. Gabay T., Krugliak M., Shalmiev G., Ginsburg H. Inhibition by anti-malarial drugs of hemoglobin denaturation and Fe release in acidified red blood cell lysates - a possible mechanism of their anti-malarial effect. Parasitology. 108:1994;371-381.
19. Pollack S., Schnelle V. Inability to detect transferrin receptors on P. falciparum parasitized red cells. Br. J. Haematol. 68:1988;125-129.
20. Scott M.D., Ranz A., Kuypers F.A., Lubin B.H., Meshnik S.R. Parasite uptake of desferrioxamine: a prerequisite for antimalarial activity. Br. J. Haematol. 75:1990;598-602.
21. Loyevsky M., Lytton S., Mester B., Libman J., Shanzer A., Cabantchik Z.I. The antimalarial action of desferal involves a direct access route to erythrocytic (Plasmodium falciparum) parasites. J. Clin. Invest. 91:1993;218-224.
22. Slater A.F., Cerami A. Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites. Nature. 355:1992;167-169.
23. Lytton SD, Loyevsky M, Libman J, Mester B, Shanzer A, Cabantchik ZI. The biochemical basis for the selective antimalarial action of iron chelators on Plasmodium falciparum parasitized cells. In: Hershko C, Konijn AM, Aisen P, editors, Progress in iron Research. New York: Plenum Press, 1994: 385-397.
24. Epsztejn S., Kakhlon O., Glickstein H., Breuer B., Cabantchik Z.I. Fluorescence analysis of the labile iron pool of mammalian cells. Anal. Biochem. 248:1997;31-40.
25. Loyevsky M., John C., Zaloujnyi I., Gordeuk V.R. Aminothiol multidentate chelators as antimalarials. Biochem. Pharmacol. 54:1997;451-458.
26. Breuer W., Epsztejn S., Millgram P., Cabantchik Z.I. Transport of iron and other transition metals into cells as revealed by a fluorescent probe. Am. J. Physiol. (Cell Physiol.). 268:1995;C1354-C1361.
27. Trost L.C., Lemasters J.J. Role of the mitochondrial permeability transition in salicylate toxicity to cultured rat hepatocytes: implications for the pathogenesis of Reye's Syndrome. Toxicol. Appl. Pharmacol. 147:1997;431-441.
28. Haugland RD, 1996, Handbook of Fluorescent Probes and Research Chemicals, 6th Edition. In: Spence MTZ, editor. Molecular Probes, 681 p.
29. Berger B.J., Bendrat K., Cerami A. High-performance liquid chromatographic analysis of biological and chemical heme polymerization. Anal. Biochem. 231:1995;151-156.
30. John C.S., Pillai M.R.A., Lo J.M., Troutner D.E. Labeling of proteins with Rh-105. J. Appl. Rad. Isotope. 40:1989;701-710.
31. Pillai M.R.A., John C.S., Lo J.M., Schlemper E.O., Troutner D.E. Oxo-bis-oxo dinuclear complexes of technetium (V) with amine phenol ligands: synthesis, characterization and X-ray crystal structures. Inorg. Chem. 29:1990;1850-1861.
32. Sillen LG, Martell AE, 1964, Stability Constants, Special Publ. No 17, The Chemical Society, London.
33. Goodwin J.F., Whitten C.F. Chelation of ferrous sulfate solutions by desferrioxamine B. Nature. 205:1965;281-283.
34. Auld D.S. Use of chelating agents to inhibit enzymes. Meth. Enzymol. 158:1988;110-114.
35. Trager W., Jensen J.B. Continuous culture of human malaria parasites. Science (Washington, D.C.). 193:1976;673-675.
36. Lambros C., Vanderberg J.P. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J. Parasitol. 65:1979;418-420.
37. Orjih A.U., Fitch C.D. Hemozoin production by Plasmodium falciparum: variation with strain and exposure to chloroquine. Biochim. Biophys. Acta. 1157:1993;270-274.
38. Orjih A.U., Banyal H.S., Chevli R., Fitch C.D. Hemin lyses malaria parasites. Science. 214:1981;667-669.
39. Tanabe K., Mikkelsen R.B., Wallach D.F.H. Calcium transport of Plasmodium chabaudi-infected erythrocytes. J. Cell Biol. 93:1982;680-684.
40. Garcia C.R., Dluzewski A.R., Catalani L.H., Burting R., Hoyland J., Mason W.T. Calcium homeostasis in intraerythrocytic malaria parasites. Eur. J. Cell Biol. 71:1996;409-413.
41. Yayon A., Cabantchik Z.I., Ginsburg H. Identification of the acidic compartment of Plasmodium falciparum-infected human erythrocytes as the target of the antimalarial drug chloroquine. EMBO J. 3:1984;2695-2700.
42. Jensen J.B. Concentration from continuous culture of erythrocytes infected with trophozoites and schizonts of Plasmodium falciparum. Am. J. Trop. Med. Hyg. 27:1978;1274-1276.
43. Cabantchik Z.I., Glickstein H., Milgram P., Breuer W. A fluorescence assay for assessing chelation of intracellular iron in a membrane model system and in mammalian cells. Anal. Biochem. 233:1996;221-227.
44. Nyholm S, Mann GI, Johanson AG, Bergeron RJ, Graslund A, Thelander L. Role of ribonucleotide reductase in inhibition of mammalian cell growth by potent iron chelators. J. Biol. Chem. 1993;268:26200-5.
45. Mabeza G., Loyevsky M., Gordeuk V.R., Weiss G. Iron chelation therapy for malaria: a review. Pharmacol. Ther. 81:1999;53-75.
46. Ferrali M., Signorini C., Ciccoli L., Comporti M. Iron release and membrane damage in erythrocytes exposed to oxidizing agents, phenylhydrazine, divicine and isouramil. Biochem. J. 285:1992;293-301.
47. Cabantchik Z.I. Properties of permeation pathways induced in the human red cell membrane by malaria parasites. Blood Cells. 16:1990;421-432.
48. Tsafack A., Libman J., Shanzer A., Cabantchik Z.I. Chemical determinants of antimalarial activity of reversed siderophores. Antimicrob. Agents Chemother. 40:1996;2160-2166.
49. Atamna H., Ginsburg H. Origin of reactive oxygen species in erythrocytes infected with Plasmodium falciparum. Mol. Biochem. Parasitol. 61:1993;231-242.
50. 2+ binding to the sarcoplasmic reticulum. Use of a high-affinity fluorescent calcium indicator. Biophys. J. 18:1977;3-22.
51. Vidal S., Gros P., Skamene E. Natural resistance to infection with intracellular parasites: molecular genetics identifies Nramp1 as the Bcg/Ity/Lsh locus. J. Leukoc. Biol. 58:1995;382-390.
52. Gunshin H., Mackenzie B., Berger U.V., Gunshin Y., Romero M.F., Boron W.F., Nussberger S., Gollan J.L., Hediger M.A. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature. 388:1997;482-488.